Evidence map›Paper›PMID 36747140›Full record

ArticleBMC public health2023

Psychoactive substance abuse among commercial bus drivers in Umuahia, Abia State, South-Eastern Nigeria: an uncontrolled "epidemic" with attendant road traffic crashes.

Roseline Oluyemisi Akande, Joel Olufunminiyi Akande, Olaniyan Akintunde Babatunde, Adeola Olajumoke Ajayi, Akindele Amos Ajayi, Roseline Olabisi Ige, Ajedotun Shittu Saliu, Abayomi Akande, Muideen Babatunde Olatunji

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Roseline Oluyemisi AkandeDepartment of Community Medicine, LAUTECH, Ogbomoso, Oyo State, Nigeria.
Joel Olufunminiyi AkandeDepartment of Chemical Pathology, LAUTECH, Ogbomoso, Oyo State, Nigeria.
Olaniyan Akintunde BabatundeOyo State Primary Health Care Board, State Secretariat, Agodi, Ibadan, Oyo State, Nigeria. tundebabson23@gmail.com.
Adeola Olajumoke AjayiDepartment of Psychiatry, Uniosun Teaching Hospital, Osogbo, Osun State, Nigeria.
Akindele Amos AjayiDepartment of Family Medicine, Uniosun Teaching Hospital, Osogbo, Osun State, Nigeria.
Roseline Olabisi IgeDepartment of Community Medicine, LAUTECH Teaching Hospital, Ogbomoso, Oyo State, Nigeria.
Ajedotun Shittu SaliuAl Kamil General Hospital, Al Kamil, Makkah Province, Saudi Arabia.
Abayomi AkandeDepartment of Community Medicine, Faculty of Public Health, College of Medicine, University of Ibadan, Oyo State, Ibadan, Nigeria.
Muideen Babatunde OlatunjiOyo State Primary Health Care Board, State Secretariat, Agodi, Ibadan, Oyo State, Nigeria.
Ladoke Akintola University of Technology · NGOsun State University · NGLadoke Akintola University of Technology Teaching Hospital · NGOklahoma State Department of Health · USOndo State Primary Health Care Development Board · NGUniversity of Ibadan · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background informationThe unprecedented depletion of the productive workforce has been majorly attributed to road traffic crashes (RTCs). The attendant consequences of this depletion have been found to constitute a serious global public health challenge, with the use of psychoactive substances among drivers implicated in every three of five motor vehicle accidents. Hence, this study assessed the pattern and explored the determinants of substance abuse among commercial bus drivers in Umuahia, Abia State.

methodsA descriptive cross-sectional design was used for the study. Four hundred commercial bus drivers were recruited from selected motor parks in Abia-state, using a multistage sampling technique from October to December 2020. A pretested, interviewer-administered questionnaire was administered to obtain socio-demographics and information on substance abuse. Data were analyzed using IBM SPSS version 25; bivariate analysis was done using Chi-square. The level of significance was at 5%.

resultsThe mean age of the respondents was 40.03 ± 10.50 years. The proportion of respondents who had ever abused a psychoactive substance was 74.6%. The most commonly abused substances among drivers include alcohol (51%), cigarettes (27%), and alcoholic herbal mixtures (16%). The study participants had poor knowledge (54.5%) and poor perception (63.2%) about psychoactive substance abuse. Among the factors found to be significantly associated with substance abuse among respondents were ethnicity (p = 0.002), religion (p = 0.009) and monthly income (p = 0.013) of the respondents, poor knowledge (p < 0.001) and poor perception (p < 0.001). However, this study found religion (p = 0.031; OR = 5.469; CI = 1.170 to 25.555), knowledge (p < 0.001; OR = 4.21; CI = 2.201 to 8.287) and perception (p < 0.001; OR = 9.828; CI = 15.572 to 65.052) as factors that were associated with the higher likelihood of psychoactive substance abuse.

conclusionReligion, poor knowledge and perception were associated with the higher likelihood of psychoactive substance abuse among commercial bus drivers. Targeting commercial bus drivers for educational interventions and using religious leaders as conveyor belts may reduce the use of psychoactive substances among them.

Indexed as

Automobile DrivingSubstance-Related DisordersAccidents, TrafficAdultCross-Sectional StudiesHumansMiddle AgedNigeriaPsychotropic DrugsPsychotropic DrugsBus DriversCommercialRoad traffic crashesSubstance abuse

Identifiers

PMID36747140
PMCPMC9901138
OpenAlexW4319298429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.